Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oliver Rath

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
FEBS Letters|November 14, 2006
Regulation of RKIP binding to the N-region of the Raf-1 kinaseSungdae Park, Oliver Rath, Sandy Beach, et al.
Journal of Medicinal Chemistry|January 18, 2012
Triphenylbutanamines: kinesin spindle protein inhibitors with in vivo antitumor activityFang Wang, James A D Good, Oliver Rath, et al.
Journal of Medicinal Chemistry|February 12, 2013
Optimized S-trityl-L-cysteine-based inhibitors of kinesin spindle protein with potent in vivo antitumor activity in lung cancer xenograft modelsJames A D Good, Fang Wang, Oliver Rath, et al.
European Journal of Medicinal Chemistry|July 4, 2012
Doing the methylene shuffle--further insights into the inhibition of mitotic kinesin Eg5 with S-trityl L-cysteineMurad N Abualhasan, James A D Good, Kitiyaporn Wittayanarakul, et al.
Cancer Research|February 10, 2011
Raf kinase inhibitor protein RKIP enhances signaling by glycogen synthase kinase-3βFahd Al-Mulla, Milad S Bitar, May Al-Maghrebi, et al.
Cellular Signalling|February 26, 2008
The RKIP (Raf-1 Kinase Inhibitor Protein) conserved pocket binds to the phosphorylated N-region of Raf-1 and inhibits the Raf-1-mediated activated phosphorylation of MEKOliver Rath, Sungdae Park, Hui-hui Tang, et al.
Molecular and Cellular Biology|September 18, 2013
Extracellular signal-regulated kinase regulates RhoA activation and tumor cell plasticity by inhibiting guanine exchange factor H1 activityAnne von Thun, Christian Preisinger, Oliver Rath, et al.
Translational Oncology|June 9, 2016
BEZ235 (PIK3/mTOR inhibitor) Overcomes Pazopanib Resistance in Patient-Derived Refractory Soft Tissue Sarcoma CellsHee Kyung Kim, Sun Young Kim, Su Jin Lee, et al.
Translational Oncology|March 23, 2017
Development of Novel Patient-Derived Preclinical Models from Malignant Effusions in Patients with Tyrosine Kinase Inhibitor-Resistant Clear Cell Renal Cell CarcinomaJiryeon Jang, Oliver Rath, Julia Schueler, et al.
Oncotarget|November 6, 2015
LIM kinase inhibitors disrupt mitotic microtubule organization and impair tumor cell proliferationKaterina Mardilovich, Mark Baugh, Diane Crighton, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
FEBS Letters|November 14, 2006
Regulation of RKIP binding to the N-region of the Raf-1 kinaseSungdae Park, Oliver Rath, Sandy Beach, et al.
Journal of Medicinal Chemistry|January 18, 2012
Triphenylbutanamines: kinesin spindle protein inhibitors with in vivo antitumor activityFang Wang, James A D Good, Oliver Rath, et al.
Journal of Medicinal Chemistry|February 12, 2013
Optimized S-trityl-L-cysteine-based inhibitors of kinesin spindle protein with potent in vivo antitumor activity in lung cancer xenograft modelsJames A D Good, Fang Wang, Oliver Rath, et al.
European Journal of Medicinal Chemistry|July 4, 2012
Doing the methylene shuffle--further insights into the inhibition of mitotic kinesin Eg5 with S-trityl L-cysteineMurad N Abualhasan, James A D Good, Kitiyaporn Wittayanarakul, et al.
Cancer Research|February 10, 2011
Raf kinase inhibitor protein RKIP enhances signaling by glycogen synthase kinase-3βFahd Al-Mulla, Milad S Bitar, May Al-Maghrebi, et al.
Cellular Signalling|February 26, 2008
The RKIP (Raf-1 Kinase Inhibitor Protein) conserved pocket binds to the phosphorylated N-region of Raf-1 and inhibits the Raf-1-mediated activated phosphorylation of MEKOliver Rath, Sungdae Park, Hui-hui Tang, et al.
Molecular and Cellular Biology|September 18, 2013
Extracellular signal-regulated kinase regulates RhoA activation and tumor cell plasticity by inhibiting guanine exchange factor H1 activityAnne von Thun, Christian Preisinger, Oliver Rath, et al.
Translational Oncology|June 9, 2016
BEZ235 (PIK3/mTOR inhibitor) Overcomes Pazopanib Resistance in Patient-Derived Refractory Soft Tissue Sarcoma CellsHee Kyung Kim, Sun Young Kim, Su Jin Lee, et al.
Translational Oncology|March 23, 2017
Development of Novel Patient-Derived Preclinical Models from Malignant Effusions in Patients with Tyrosine Kinase Inhibitor-Resistant Clear Cell Renal Cell CarcinomaJiryeon Jang, Oliver Rath, Julia Schueler, et al.
Oncotarget|November 6, 2015
LIM kinase inhibitors disrupt mitotic microtubule organization and impair tumor cell proliferationKaterina Mardilovich, Mark Baugh, Diane Crighton, et al.
Pageof 3